eMail:  peytond@pdx.edu
 

Other Appointments:  
| Ph.D. | 1983 | |
| Postdoctoral | 1983
                    - 1985 | |
| Postdoctoral | 1985
                    - 1987 | |
| Visiting
                    Scholar | 2000 | |
| Visiting
                    Professor | 2004 | 
 
What are others saying about
          us?
 
 
 
 
 
 
 
 
Teaching:
PSU uses D2L for classes;
              login from https://d2l.pdx.edu/
          
Research:
The main
          research theme in the Peyton research group is the study of
          the relation of structure to function in biological molecules
          by application of nuclear magnetic resonance spectroscopy.
          However, other tools may be used, depending on the nature of a
          particular problem. These tools include organic synthesis,
          electronic spectroscopy, and computer modeling/dynamics.
The
          following is a ‘gallery’ of some of the specific projects that
          are currently being investigated. Some of these projects are
          fairly mature, while others are just getting started.
| Reversed Chloroquines as
                    Antimalarial Agents | Chloroquine (CQ) is one
                    of the safest and most effective drugs ever
                    developed, but resistance has emerged against it. We
                    have developed a way to modify CQ to circumvent this
                    problem. | 
 | 
| Antimalarial
drug
                    design: This
                    is being done in collaboration with Michael
                      Riscoe, of the Portland VA
                      Hospital. | Xanthones
bind
                    to heme, making them potential agents against
                    parasites causing diseases, including malaria and
                    leishmaniasis. | 
 | 
| Collagen This
                    is being done in collaboration with Hans
                      Peter Bächinger, of the Portland
Shriners
                      Hospital. | After
                    so many years as a textbook case, we still don’t
                    really know the canonical reasons for the stability
                    of collagen, our most abundant protein. We are
                    particularly interested in glycosylated collagens,
                    lacking hydroxyproline. | 
 | 
| Nicotine
in
                    cigarette smoke This
                    is being done in collabaration with Jim
                      Pankow, of the Oregon
                      Graduate Institute/OH&SU. | The
                    amount and the protonation state of nicotine in
                    cigarette smoke are key factors in both traditional
                    and ‘reduced harm’ cigarettes. NMR provides a way to
                    assess these quantities. | 
 | 
        Selected
          & Recent Publications:
Synthesis, Structure-Activity Relationship,
        & Mode-of-Action Studies of Antimalarial Reversed
        Chloroquine Compounds
        Burgess, S.J., Kelly, J.X., Shomloo, S., Wittlin, S., Brun, R.,
        Liebmann, K., & Peyton, D.H. (2010) J. Med. Chem., 53,
        6477-6489
        
        Reversal Agent and Linker Variants of Reversed Chloroquines:
        Activities against Plasmodium falciparum
        Andrews, S., Burgess, S.J., Skaalrud, D., Kelly, J.X., &
        Peyton,  D.H. (2010) J. Med. Chem., 53, 916–919
        
        Effect of the
        -Gly-3(S)-hydroxyprolyl-4(R)-hydroxyprolyltripeptide unit on the
        stability of collagen model peptides
        Mizuno, K., Peyton, D.H., Hayashi, T., Engel, J., &
        Bächinger, H.P. (2008) FEBS J., 275, 5830-5840
        
        An Expression System to Screen for Inhibitors of Parasite
        Glucose Transporters
        Landfear, S.M., Feistel, T., Hodson, C.A., & Peyton, D.H.
        (2008) Mol. Cell. Parasitol., 162, 71-76
      
Synthesis and heme-binding correlation with
        antimalarial activity of
        3,6-bis-(omega-N,N-diethylaminoamyloxy)-4,5-difluoroxanthone
        Dodean, R.A., Kelly, J.X., Peyton, D.H., Gard, G.L., Riscoe,
        M.K., & Winter, R.W. (2008) Bioorg. Med. Chem. 16, 1174-1183
      
Tobacco smoke particulate matter chemistry by
        NMR
        Barsanti K.C., Luo W., Isabelle L.M., Pankow J.F., Peyton D.H.
        (2007) Magn. Reson. Chem. 459, 167-170
A Chloroquine-like Molecule Designed to
        Reverse Resistance in Plasmodium falciparum
          Burgess, S. J.; Selzer, A.; Kelly, J. X.; Smilkstein, M. J.;
          Riscoe, M. K.; Peyton, D. H. (2006) J. Med. Chem. 49,
          5623-5625
The Peptides
          Acetyl-(Gly-3(S)Hyp-4(R)Hyp)10-NH2 and
          Acetyl-(Gly-Pro-3(S)Hyp))10-NH2 do not
          form a Collagen Triple Helix
          K. Mizuno, T, Hayashi, D.H. Peyton, & H.P Bächinger (2004)
          J. Biol. Chem., 279, 282-287
The role of carbohydrate in
          stabilizing the triple-helix in a model for a deep-sea
          hydrothermal vent worm collagen
          J.G. Bann, H.P. Bächinger, & D.H. Peyton (2003)
          Biochemistry, 42, 4042-4048
Fraction of Free-Base Nicotine
          in Fresh Smoke Particular Matter from the Eclipse “Cigarette”
          by 1H NMR Spectroscopy
          J.F. Pankow, K.C Barsanti, & D.H. Peyton (2003) Chem. Res.
          Toxicol., 16, 23-27
Antileishmanial Drug
          Development: Exploitation of Parasite Heme Dependency
          J.X. Kelly, M.V. Ignatuschenko, R.W. Winter, H.G. Bouwer, D.H.
          Peyton, D.J. Hinrichs, & M. Riscoe (2003) Mol. Biochem.
          Parasitol., 126, 43-49
A Circularly Permuted
          Myoglobin Possesses a Folded Structure and Ligand Binding
          Similar to Wild-type Protein but with Reduced Thermodynamic
          Stability
          A.L. Fishburn, J.R. Keeffe, A.V. Lissounov, D.H. Peyton, &
          S.J. Anthony-Cahill (2002) Biochemistry, 41, 13318-13327
The Kinetics of Uptake and
          Accumulation of 3,6-w-diethylaminoamyloxyxanthone by the Human
          Malaria parasite Plasmodium falciparum
          J.X. Kelly, R.W. Winter, A. Cornea, D.H. Peyton, D.J.
          Hinrichs, & M. Riscoe (2002) Mol. Biochem. Parasitol.,
          123,  47-54
Optimization of Xanthones for
          Antimalarial Activity, the 3,6-w-diethylaminoalkoxyxanthone Series
          J.X. Kelly, R. Winter, D.H. Peyton, D.J. Hinrichs, & M.K.
          Riscoe (2002) Antimicrob.  Agts. Chemo., 46, 144-150
Antileishmanial Drug
          Development: Exploitation of Parasite Heme Dependency
          J.X. Kelly, M.V. Ignatuschchenko, R.W. Winter, H.G. Bouwer,
          D.H. Peyton, D.J. Hinrichs, & M. Riscoe (2002) Mol.
          Biochem. Parasitol., 123, 47-54